98%
921
2 minutes
20
Motivation: Drug recommendation aims to allocate safe and effective drug combinations based on the patient's health status from electronic health records, which is crucial to assist clinical physicians in making decisions. However, the existing drug recommendation works face two key challenges: (i) difficulty in fully representing the patient's health status leads to biased drug representation; (ii) only focusing on diagnostic representations of multiple visits, neglecting the modeling of patient drug history.
Results: To address the above limitations, we propose a multi-view gating retrieval network (MGRN) for robust drug recommendation. We design visit-, sequence-, and token-level views to provide different perspectives on the interaction between patients and drugs, obtaining a more comprehensive representation of drugs. Moreover, we develop a gating drug retrieval module to capture critical drug information from multiple visits, which can assist in recommending more reasonable drug combinations for the current visit. When evaluated on publicly real-world MIMIC-III and MIMIC-IV datasets, the proposed MGRN establishes a new benchmark performance, particularly achieving improvements of 1.36%, 1.71%, 1.21% and 2.12%, 2.36%, 1.81% in Jaccard, PRAUC, and F1-score, respectively, compared to state-of-the-art models.
Availability And Implementation: The code is available at: https://github.com/kyosen258/MGRN.git.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11470236 | PMC |
http://dx.doi.org/10.1093/bioinformatics/btae572 | DOI Listing |
Front Microbiol
August 2025
Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS, Unites States.
Globally, and have been associated with human gastroenteritis. More importantly, there are increasing reports of strains that are resistant to commonly used antimicrobials. In Rwanda, the prevalence and the antimicrobial susceptibility profiles of thermophilic strains remain underexplored.
View Article and Find Full Text PDFIndoor Air
January 2025
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Background/objectives: Respiratory viruses circulate year-round and can spread indoors via inhalation of airborne particles. Effective ventilation and filtration may reduce transmission, particularly in school settings where children and staff spend significant time. This study examines the impact of indoor air quality (IAQ) and ventilation in schools on respiratory virus detection.
View Article and Find Full Text PDFAddict Behav Rep
June 2025
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
This article proposes minimum requirements for reporting efficacy in treatment studies of compulsive sexual behavior (CSB). CSB disorder (CSBD) is a condition whose diagnostic criteria were only recently defined by the World Health Organization. Multiple primary and secondary outcomes have been used in treatment trials of CSB, and possible neuropsychological measures have been considered.
View Article and Find Full Text PDFCureus
August 2025
Department of Urology, The Institute of Medical Science, The University of Tokyo, Tokyo, JPN.
In patients with advanced urothelial carcinoma who have progressed after platinum-based chemotherapy, enfortumab vedotin (EV) improves overall survival compared to standard chemotherapy. Additionally, for treatment-naïve patients with locally advanced or metastatic urothelial carcinoma, the combination of pembrolizumab and EV demonstrates superior efficacy over platinum-based chemotherapy. Hence, EV becomes a standard treatment option.
View Article and Find Full Text PDFEClinicalMedicine
October 2025
Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Background: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are established treatments for obesity. However, it remains inconclusive whether the combination of lifestyle modifications and GLP-1RA interventions can lead to greater weight loss and better control of cardiovascular biomarkers. We aimed to evaluate the efficacy of this combination therapy on weight loss and cardiometabolic markers in adults with overweight or obesity.
View Article and Find Full Text PDF